Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions

Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions

Andreas O Doesch,1,* Li Zhao,1,* Christian A Gleissner,1 Mohammadreza Akhavanpoor,1 David Rohde,1 Deniz Okuyucu,1 Maani Hakimi,2 Thomas J Dengler,3 Hugo A Katus,1 Christian Erbel1 1Department of Cardiology, 2Department of Vascular Surgery, University of Heidelberg, Germany; 3Department of Cardiolog...

Full description

Bibliographic Details
Main Authors: Doesch AO, Zhao L, Gleissner CA, Akhavanpoor M, Rohde D, Okuyucu D, Hakimi M, Dengler TJ, Katus HA, Erbel C
Format: Article
Language:English
Published: Dove Medical Press 2014-05-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/inhibition-of-b7-1-cd80-by-rhudexreg-reduces-lipopolysaccharide-mediat-peer-reviewed-article-DDDT

Internet

http://www.dovepress.com/inhibition-of-b7-1-cd80-by-rhudexreg-reduces-lipopolysaccharide-mediat-peer-reviewed-article-DDDT

Similar Items